Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies - Blagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P; Patel, M; Sukumaran, A; Loyse, N; Bharwani, N; Rockall, A; Gabra, H; El-Bahrawy, M; et al. (American Society of Clinical Oncology, 2015)